| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/04/2007 | CN1323662C Pharmaceutical composition containing ambroxol and erdosteine or acetylcysteine and application thereof |
| 07/04/2007 | CN1323658C Novel dry powder inhalation system for transpulmonary administration |
| 07/04/2007 | CN1323657C High efficioncy stop smoking buccal tablets |
| 07/04/2007 | CN1323656C Medicine for treating rheumatic arthritis and preparation technology of its spray agent |
| 07/03/2007 | USRE39713 And also containing water-soluble polymeric block(s), and at least one polymerizable group; used to encapsulate cells, deliver prophylactic, therapeutic or diagnostic agents, plug leaks in tissue, prevent adhesion formation after surgical procedures, and protect or seal tissue surfaces |
| 07/03/2007 | US7238761 Gel of an acrylamide-methacrylamide copolymer crosslinked with 2-hydroxyethyl methacrylate and N,N'-methylene-bis-acrylamide, and water; use as carrier for culturing heterogeneous (allogenic or xenogenic) or autoimmune cells |
| 07/03/2007 | US7238734 Drug delivery; improved refractive index, transparency to light, reflection, permeability, coercivity, magnetic hysteresis, breakdown voltage, biocompatability, and wear resistance |
| 07/03/2007 | US7238705 Aporphine esters and their use in therapy |
| 07/03/2007 | US7238680 Topical compositions for veterinary uses |
| 07/03/2007 | US7238673 Genetic enginnering; kits |
| 07/03/2007 | US7238665 Mimetic peptide conjugated to therapeutic liposome for use as a drug delivery tool in treatment of cell proliferative disorders; tissue engineering |
| 07/03/2007 | US7238481 administering HETEROLOGOUS GENE PRODUCTS IN HOST CELL SYSTEMS AND/OR TO RESCUE NEGATIVE STRAND RNA RECOMBINANT VIRUSES |
| 07/03/2007 | US7238371 contacting a reducing agent with a therapeutic agent encapsulated with a proteinoid microsphere comprising a mixture of amino acids that are thermally condensed and crosslinked with a crosslinker and can form a pore when exposed to a reducing agent |
| 07/03/2007 | US7238370 Method and composition to prevent and treat photoaging of skin |
| 07/03/2007 | US7238369 a cationic lipid; and a taxane in a lipid bilayer of the taxane crystal free liposome |
| 07/03/2007 | US7238368 Releasable linkage and compositions containing same |
| 07/03/2007 | US7238367 Liposome loading with metal ions |
| 07/03/2007 | US7238366 Submicron liposome suspensions obtained from preliposome lyophilizates |
| 07/03/2007 | US7238364 Barrier or drug delivery system; conformation to three-dimensional structure; biodegradable, biocompatible |
| 07/03/2007 | US7238361 Smart drug delivery system |
| 07/03/2007 | US7238357 Methods for treating ulcers and gastroesophageal reflux disease |
| 07/03/2007 | US7238349 Composition |
| 07/03/2007 | CA2447510C Fluorocarbon aerosol medicaments |
| 07/03/2007 | CA2393585C Therapeutic agents |
| 07/03/2007 | CA2367131C Methods for fine powder formation |
| 07/03/2007 | CA2350884C Topical compositions comprising ascomycins |
| 07/03/2007 | CA2328945C Softgel-compatible composition containing retinol |
| 07/03/2007 | CA2319096C Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
| 07/03/2007 | CA2296425C Bright white film coatings and film coating compositions therefor |
| 07/03/2007 | CA2295199C Method for treating vascular proliferative diseases with p27 and fusions thereof |
| 07/03/2007 | CA2277429C A lactoferrin tablet |
| 07/03/2007 | CA2174122C Therapeutic delivery compositions and methods of use thereof |
| 07/03/2007 | CA2108192C Use of tyloxapol as a nanoparticle stabilizer and dispersant |
| 06/29/2007 | CA2572112A1 System and kit treating tissue with radio frequency vascular electrode array |
| 06/29/2007 | CA2572106A1 Low temperature drying methods for forming drug-containing polymeric compositions |
| 06/29/2007 | CA2572100A1 Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same |
| 06/28/2007 | WO2007073389A1 Compressed solid dosage forms with drugs of low solubility and process for making the same |
| 06/28/2007 | WO2007073346A1 Water-soluble films comprising low-viscosity alginates |
| 06/28/2007 | WO2007073265A1 Absorbent article |
| 06/28/2007 | WO2007073264A1 Absorbent article |
| 06/28/2007 | WO2007073137A1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli |
| 06/28/2007 | WO2007073035A1 Method for preparing microspheres of polymer and manufacturing apparatus therof |
| 06/28/2007 | WO2007072992A2 Solid preparation containing an insulin sensitizer |
| 06/28/2007 | WO2007072983A1 Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure |
| 06/28/2007 | WO2007072923A1 Preparation for external use having improved temporal stability of steroid |
| 06/28/2007 | WO2007072911A1 Preparation with improved bioabsorbability of sapropterin hydrochloride |
| 06/28/2007 | WO2007072908A1 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
| 06/28/2007 | WO2007072840A1 Orally disintegrating tablet comprising fat-soluble substance |
| 06/28/2007 | WO2007072535A2 Microparticulate systems for the oral administration of biologically active substances |
| 06/28/2007 | WO2007072495A2 Coated tablets having prolonged gastric retention |
| 06/28/2007 | WO2007072380A2 Method of making dried particles |
| 06/28/2007 | WO2007072297A2 Device for controlled release of chemical molecules |
| 06/28/2007 | WO2007072216A2 Kit and composition of imidazole with enhanced bioavailability |
| 06/28/2007 | WO2007072106A1 Method for preparing particles from an emulsion in supercritical or liquid co2 |
| 06/28/2007 | WO2007071915A2 Pharmaceutical product comprising porous silicon |
| 06/28/2007 | WO2007071876A1 Composition of inverse emulsion type comprising ivermectin, and uses thereof in cosmetics and dermatology |
| 06/28/2007 | WO2007071721A2 Ginger extract for inhibiting human drug transporters |
| 06/28/2007 | WO2007071708A2 Ginger fraction for inhibiting human cyp enzymes |
| 06/28/2007 | WO2007071581A2 Pharmaceutical formulation for producing rapidly disintegrating tablets |
| 06/28/2007 | WO2007071580A1 Finely dispersed cross-linked polyvinylpyrrolidone for use as tablet disintegrant |
| 06/28/2007 | WO2007071512A1 Spherical menthol particles |
| 06/28/2007 | WO2007071420A1 Bursting pellets |
| 06/28/2007 | WO2007071395A1 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| 06/28/2007 | WO2007071240A1 A plant and a process for production of tablets |
| 06/28/2007 | WO2007071159A1 The use of anthraquinone derivatives for preparation of medicaments against influenza and “bird flu” viruse |
| 06/28/2007 | WO2007071036A1 Emulsions comprising non-esterified phytosterols in the aqueous phase |
| 06/28/2007 | WO2007071012A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor |
| 06/28/2007 | WO2007070983A1 Transdermal delivery of pharmaceutical agents |
| 06/28/2007 | WO2007056125A3 Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances |
| 06/28/2007 | WO2007053424A3 Silicone vesicles containing actives |
| 06/28/2007 | WO2007041079A3 Banded controlled release nanoparticle active agent formulation dosage forms and methods |
| 06/28/2007 | WO2007030902B1 Improved pharmaceutical composition containing artichoke extract, and process for its production |
| 06/28/2007 | WO2007024961A3 Bazedoxifene acetate formulations and manufacturing process thereof |
| 06/28/2007 | WO2007023325A3 Controlled release pharmaceutical composition containing carvedilol |
| 06/28/2007 | WO2007019540A3 Controlled release alpha-lipoic acid formulation with an inositol compound |
| 06/28/2007 | WO2007019224A3 Formulations and methods for enhancing the transdermal penetration of a drug |
| 06/28/2007 | WO2007017219A3 Pharmaceutical form with sustained ph-independent active ingredient release for active ingredients having strong ph-dependent solubility |
| 06/28/2007 | WO2007016563A3 Alcohol resistant pharmaceutical formulations |
| 06/28/2007 | WO2007016315A3 Extended release venlafaxine compositions |
| 06/28/2007 | WO2007009800A3 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent |
| 06/28/2007 | WO2007008927A3 Bioresorbable composition for repairing skeletal tissue |
| 06/28/2007 | WO2007008894A3 Cyclosporin compositions |
| 06/28/2007 | WO2007002183A3 Drug delivery device for implanting in the eye comprising a drug core and a preformed permeable crystalline polymeric disc |
| 06/28/2007 | WO2007000779A3 Pharmaceutical sustained release compositions and processes thereof |
| 06/28/2007 | WO2006135491A3 Medicament carrier composition and method of forming a film therefrom |
| 06/28/2007 | WO2006122309A3 Stable lyophilized anthracycline glycosides |
| 06/28/2007 | WO2006116597A3 Methods and devices for performing procedures within the ear, nose, throat and paranasal sinuses |
| 06/28/2007 | WO2006115713A3 Eutectic blends containing a water soluble vitamin derivative |
| 06/28/2007 | WO2006103661A3 Controlled absorption of statins in the intestine |
| 06/28/2007 | WO2006096426A3 Targeted drug delivery of pain and addiction therapies using opioid receptor-mediated internalization |
| 06/28/2007 | WO2006028747A3 Counter pressure device for ophthalmic drug delivery |
| 06/28/2007 | WO2005120465A3 Multi-layer tablet comprising non-steroidal anti-inflammatory drugs decongestants and non-sedating antihistamines |
| 06/28/2007 | WO2005053637A3 Pharmaceutical spray formulation comprising a hypro fluor alkane amd an acylated cyclodextrin |
| 06/28/2007 | US20070149954 Acoustically controlled substance delivery device |
| 06/28/2007 | US20070149953 System for delivering anesthesia drugs to a patient |
| 06/28/2007 | US20070149952 Systems and methods for characterizing a patient's propensity for a neurological event and for communicating with a pharmacological agent dispenser |
| 06/28/2007 | US20070149945 Valved intradermal delivery device and method of intradermally delivering a substance to a patient |
| 06/28/2007 | US20070149694 Contains two ethylenically unsaturated monomers; drug delivery; emulsion polymerization; incorporates or encapsulates large amounts of bioactive ingredients including hydrophobic components without substantially degrading the bioactive agent |
| 06/28/2007 | US20070149693 latex containing butadiene-methacrylic acied-styrene copolymer which is toluene insoluble; coated glove provides excellent touch and feel, sufficient tensile strength and elongation at break, and an excellent persistence of close fitting |
| 06/28/2007 | US20070149454 Controlled Release Delivery System for Nasal Applications and Method of Treatment |